Status:
RECRUITING
Novel Visual Education Tool to Improve Recognition and Reporting of Postpartum Urgent Maternal Warning Signs
Lead Sponsor:
Northwestern University
Conditions:
Postpartum
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study aims to create a novel visual education tool that builds on the urgent maternal warning signs identified by The Council on Patient Safety in Women's Health Care. Including effective images ...
Eligibility Criteria
Inclusion
- Postpartum women
- Nulliparity
- Age \>18 years of age
- English speaking patients
Exclusion
- Inability to provide informed written consent
- Refusal to participate in all study-related procedures
- Patients not fluent in English
- Patients with current or history of serious peripartum complications and/or events - such as DVT, PE, peripartum cardiomyopathy, etc. (in which the patient may have received more than standard clinical counseling)
- Patient with comorbidities that potentially require anticoagulation i.e. coagulopathies and may be more prone to DVTs
- Patients with uncorrected visual or hearing impairment
- Healthcare providers (in which patients will have significant background knowledge)
Key Trial Info
Start Date :
June 20 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06912776
Start Date
June 20 2025
End Date
August 1 2026
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Medicine
Chicago, Illinois, United States, 60614